• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The link between bone and coronary calcifications in CKD-5 patients on haemodialysis.血液透析的 CKD-5 患者的骨与冠状动脉钙化之间的联系。
Nephrol Dial Transplant. 2011 Mar;26(3):1010-5. doi: 10.1093/ndt/gfq491. Epub 2010 Aug 13.
2
Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.透析前慢性肾脏病中的骨保护素和硬化素:血管钙化的潜在相关因素
Nephrol Dial Transplant. 2015 Aug;30(8):1345-56. doi: 10.1093/ndt/gfv081. Epub 2015 Apr 7.
3
High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.高甲状旁腺激素水平和骨质疏松症预示着透析患者冠状动脉钙化的进展。
J Am Soc Nephrol. 2015 Oct;26(10):2534-44. doi: 10.1681/ASN.2014070686. Epub 2015 Apr 2.
4
Low bone volume--a risk factor for coronary calcifications in hemodialysis patients.低骨量——血液透析患者冠状动脉钙化的一个危险因素。
Clin J Am Soc Nephrol. 2009 Feb;4(2):450-5. doi: 10.2215/CJN.01870408. Epub 2009 Jan 21.
5
A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients.血浆骨保护素水平的截断值可能预测慢性肾脏病患者冠状动脉钙化的存在。
Nephrol Dial Transplant. 2009 Nov;24(11):3389-97. doi: 10.1093/ndt/gfp301. Epub 2009 Jul 2.
6
Bone biomarkers help grading severity of coronary calcifications in non dialysis chronic kidney disease patients.骨生物标志物有助于分级非透析慢性肾脏病患者冠状动脉钙化的严重程度。
PLoS One. 2012;7(5):e36175. doi: 10.1371/journal.pone.0036175. Epub 2012 May 2.
7
Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study.血液透析患者骨重塑变化与冠状动脉钙化的关联:一项前瞻性研究。
Am J Kidney Dis. 2008 Dec;52(6):1139-50. doi: 10.1053/j.ajkd.2008.06.024. Epub 2008 Sep 27.
8
Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study.血液透析患者中骨硬化蛋白与心血管钙化的关系:一项横断面研究。
BMC Nephrol. 2013 Oct 10;14:219. doi: 10.1186/1471-2369-14-219.
9
Bone turnover, osteopenia and vascular calcifications in hemodialysis patients. A histomorphometric and multislice CT study.血液透析患者的骨转换、骨质减少和血管钙化。一项组织形态计量学和多层螺旋CT研究。
Am J Nephrol. 2009;29(3):145-52. doi: 10.1159/000151769. Epub 2008 Aug 28.
10
Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients.ADVANCE 研究的设计和研究对象的基线特征:西那卡塞对血液透析患者血管钙化的影响。
Nephrol Dial Transplant. 2010 Jun;25(6):1916-23. doi: 10.1093/ndt/gfp762. Epub 2010 Jan 27.

引用本文的文献

1
Adynamic bone disorder in chronic kidney disease: meta-analysis and narrative review of potential biomarkers as diagnosis and therapeutic targets.慢性肾脏病中的动力缺失性骨病:作为诊断和治疗靶点的潜在生物标志物的荟萃分析与叙述性综述
Ren Fail. 2025 Dec;47(1):2530162. doi: 10.1080/0886022X.2025.2530162. Epub 2025 Jul 16.
2
Vascular calcification progression and its association with mineral and bone disorder in kidney transplant recipients.血管钙化进展及其与肾移植受者矿物质和骨代谢紊乱的关系。
Ren Fail. 2023;45(2):2276382. doi: 10.1080/0886022X.2023.2276382. Epub 2023 Nov 7.
3
Mixed uremic osteodystrophy: an ill-described common bone pathology in patients with chronic kidney disease.混合性尿毒症骨营养不良:慢性肾脏病患者中一种描述不足的常见骨病理状态。
Osteoporos Int. 2023 Dec;34(12):2003-2012. doi: 10.1007/s00198-023-06886-5. Epub 2023 Sep 2.
4
Chronic kidney disease mineral bone disorder in childhood and young adulthood: a 'growing' understanding.儿童及青年期慢性肾脏病-矿物质和骨异常:逐渐深入的认识
Pediatr Nephrol. 2024 Mar;39(3):723-739. doi: 10.1007/s00467-023-06109-3. Epub 2023 Aug 25.
5
Management of fracture risk in CKD-traditional and novel approaches.慢性肾脏病骨折风险的管理——传统方法与新方法
Clin Kidney J. 2022 Oct 22;16(3):456-472. doi: 10.1093/ckj/sfac230. eCollection 2023 Mar.
6
Bone Disease in Chronic Kidney Disease and Kidney Transplant.慢性肾脏病和肾移植中的骨骼疾病
Nutrients. 2022 Dec 29;15(1):167. doi: 10.3390/nu15010167.
7
Is Adynamic Bone Always a Disease? Lessons from Patients with Chronic Kidney Disease.骨动力不足就一定是疾病吗?来自慢性肾病患者的经验教训。
J Clin Med. 2022 Nov 30;11(23):7130. doi: 10.3390/jcm11237130.
8
Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKD.轻至中度慢性肾脏病患者中具有异常骨质量和血管钙化的低转换型肾性骨营养不良
Kidney Int Rep. 2022 Mar 6;7(5):1016-1026. doi: 10.1016/j.ekir.2022.02.022. eCollection 2022 May.
9
Bone mass measurement by DXA should be interpreted with caution in the CKD population with vascular calcification.对于患有血管钙化的慢性肾脏病患者,通过双能X线吸收法进行骨量测量时应谨慎解读。
Bone Rep. 2022 Jan 31;16:101169. doi: 10.1016/j.bonr.2022.101169. eCollection 2022 Jun.
10
Association between bone mineral metabolism and vascular calcification in end-stage renal disease.终末期肾病患者骨矿物质代谢与血管钙化的关系。
BMC Nephrol. 2022 Jan 3;23(1):12. doi: 10.1186/s12882-021-02652-z.

本文引用的文献

1
A modification of the masson trichrome technique for routine laboratory purposes.一种用于常规实验室目的的改良马森三色染色技术。
Am J Pathol. 1938 Mar;14(2):237-43.
2
How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?对于初次接受血液透析的患者,冠状动脉钙化值为零或较低时,其质保期是多久?
J Nephrol. 2009 Mar-Apr;22(2):255-62.
3
Low bone volume--a risk factor for coronary calcifications in hemodialysis patients.低骨量——血液透析患者冠状动脉钙化的一个危险因素。
Clin J Am Soc Nephrol. 2009 Feb;4(2):450-5. doi: 10.2215/CJN.01870408. Epub 2009 Jan 21.
4
Bone markers predict cardiovascular events in chronic kidney disease.骨标志物可预测慢性肾脏病患者的心血管事件。
J Bone Miner Res. 2008 Nov;23(11):1850-8. doi: 10.1359/jbmr.080610.
5
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.盐酸西那卡塞对继发性甲状旁腺功能亢进透析患者骨组织学影响的评估。
Clin Nephrol. 2008 Apr;69(4):269-78. doi: 10.5414/cnp69269.
6
Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.盐酸司维拉姆和碳酸钙对血液透析患者肾性骨营养不良的影响。
J Am Soc Nephrol. 2008 Feb;19(2):405-12. doi: 10.1681/ASN.2006101089. Epub 2008 Jan 16.
7
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).肾性骨营养不良的定义、评估及分类:改善全球肾脏病预后组织(KDIGO)的立场声明
Kidney Int. 2006 Jun;69(11):1945-53. doi: 10.1038/sj.ki.5000414.
8
The burden of kidney disease: improving global outcomes.肾脏疾病负担:改善全球预后。
Kidney Int. 2004 Oct;66(4):1310-4. doi: 10.1111/j.1523-1755.2004.00894.x.
9
Aortic calcification and the risk of osteoporosis and fractures.主动脉钙化与骨质疏松症及骨折风险
J Clin Endocrinol Metab. 2004 Sep;89(9):4246-53. doi: 10.1210/jc.2003-030964.
10
Arterial calcifications and bone histomorphometry in end-stage renal disease.终末期肾病中的动脉钙化与骨组织形态计量学
J Am Soc Nephrol. 2004 Jul;15(7):1943-51. doi: 10.1097/01.asn.0000129337.50739.48.

血液透析的 CKD-5 患者的骨与冠状动脉钙化之间的联系。

The link between bone and coronary calcifications in CKD-5 patients on haemodialysis.

机构信息

Division of Nephrology, Department of Radiology and Cardiology, School of Medicine, Ege University, Izmir, Turkey.

出版信息

Nephrol Dial Transplant. 2011 Mar;26(3):1010-5. doi: 10.1093/ndt/gfq491. Epub 2010 Aug 13.

DOI:10.1093/ndt/gfq491
PMID:20709740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3108347/
Abstract

BACKGROUND

Vascular calcifications are frequent in Stage 5 chronic kidney disease (CKD-5) patients receiving haemodialysis. The current study was designed to evaluate the associations between bone turnover/volume and coronary artery calcifications (CAC).

METHODS

In 207 CKD-5 patients, bone biopsies, multislice computed tomography of the coronary arteries and blood drawings for relevant biochemical parameters were done. The large number of CKD-5 patients enrolled allowed separate evaluation of patients with CAC versus patients without CAC and adjustment for traditional and non-traditional risk factors for CAC.

RESULTS

When all patients were analysed, associations were found between CAC and bone turnover, bone volume, age, gender and dialysis vintage. When only patients with CAC were included, there was a U-shaped relationship between CAC and bone turnover, whilst the association with bone volume was lost. In these patients, the relationship of CAC with age, gender and dialysis vintage remained.

CONCLUSIONS

Beyond the non-modifiable risk factors of age, gender and dialysis vintage, these data show that bone abnormalities of renal osteodystrophy amenable to treatment should be considered in the management of patients with CAC.

摘要

背景

在接受血液透析的 5 期慢性肾脏病(CKD-5)患者中,血管钙化很常见。本研究旨在评估骨转换/体积与冠状动脉钙化(CAC)之间的关系。

方法

在 207 例 CKD-5 患者中,进行了骨活检、冠状动脉多层计算机断层扫描和相关生化参数的血液采集。由于纳入了大量的 CKD-5 患者,因此可以分别评估有 CAC 的患者和无 CAC 的患者,并对 CAC 的传统和非传统危险因素进行调整。

结果

当分析所有患者时,发现 CAC 与骨转换、骨量、年龄、性别和透析龄有关。当仅纳入有 CAC 的患者时,CAC 与骨转换之间呈 U 形关系,而与骨量的关系则消失。在这些患者中,CAC 与年龄、性别和透析龄的关系仍然存在。

结论

除了年龄、性别和透析龄等不可改变的危险因素外,这些数据表明,应在 CAC 患者的管理中考虑可治疗的肾性骨营养不良的骨骼异常。